VSTM2A-OT1: A Potential Drug Target Or Biomarker (G285878)

Target Name: VSTM2A-OT1

NCBI ID: G285878

Other Name(s): VSTM2A overlapping transcript 1 | GS1-18A18.1

VSTM2A-OT1: A Potential Drug Target Or Biomarker

VSTM2A-OT1, also known as VSTM2A overlapping transcript 1, is a RNA molecule that has been identified as a potential drug target or biomarker. The VSTM2A gene is located on chromosome 6 and encodes for the protein VSTM2A-OT1.

VSTM2A-OT1 is a non-coding RNA molecule that has been shown to play a role in the regulation of gene expression. Studies have shown that VSTM2A-OT1 can interact with the protein known as RNA-binding protein (RBP), which is a protein that binds to specific RNA molecules. This interaction between VSTM2A-OT1 and RBP suggests that VSTM2A-OT1 may be a regulator of gene expression.

One of the potential benefits of targeting VSTM2A-OT1 as a drug target is that it is located in the nucleus and is highly expressed in various tissues, including the brain. This suggests that a drug that targets VSTM2A-OT1 may have broad effects on gene expression and cellular processes. Additionally, VSTM2A-OT1 has been shown to play a role in the regulation of neuronal differentiation and synaptic plasticity, which are important processes for the development and maintenance of neural circuits.

Another potential benefit of targeting VSTM2A-OT1 as a drug target is that it is highly expressed in various types of cancer, including neuro cancer. This suggests that a drug that targets VSTM2A-OT1 may be effective in treating a variety of cancers. Additionally, VSTM2A-OT1 has been shown to be involved in the regulation of cell cycle progression, which is important for the development and maintenance of cancer cells.

Targeting VSTM2A-OT1 as a drug target may also have potential therapeutic applications in other disease areas. For example, VSTM2A-OT1 has been shown to play a role in the regulation of stem cell proliferation and differentiation. This suggests that a drug that targets VSTM2A -OT1 may be effective in treating conditions such as cancer, where stem cell proliferation is uncontrolled. Additionally, VSTM2A-OT1 has been shown to play a role in the regulation of tissue repair and regeneration, which is important for wound healing and other wound-related injuries.

In conclusion, VSTM2A-OT1 is a RNA molecule that has been identified as a potential drug target or biomarker. The VSTM2A gene is located on chromosome 6 and encodes for the protein VSTM2A-OT1. VSTM2A-OT1 is a non-coding RNA molecule that has been shown to play a role in the regulation of gene expression and has been shown to interact with the protein known as RBP. Studies have shown that VSTM2A-OT1 is located in the nucleus and is highly expressed in various tissues, including the brain. Additionally, VSTM2A-OT1 has been shown to play a role in the regulation of neuronal differentiation and synaptic plasticity, as well as the regulation of cell cycle progression and stem cell proliferation. These properties make VSTM2A-OT1 an attractive potential drug target or biomarker for therapeutic applications.

Protein Name: VSTM2A Overlapping Transcript 1

More Common Targets